Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Anti-D (RHO) immunoglobulin 1,500unit pdr & solv inj vials
1405030A0AAAIAI
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 1,500unit soln for inj vials
1405030A0AAARAR
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 1,500units/2ml inj pfs
1405030A0AAAJAJ
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 2,500unit inj vials
1405030A0AAAPAP
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 250unit inj vials
1405030A0AAAMAM
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 5,000unit inj vials
1405030A0AAAQAQ
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 500unit inj vials
1405030A0AAANAN
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Antipressan 100mg tablets
0204000E0BEABAC
|
Antipressan | Atenolol | Cardiovascular System | No data available |
|
Antipressan 25mg tablets
0204000E0BEACAG
|
Antipressan | Atenolol | Cardiovascular System | No data available |
|
Antipressan 50mg tablets
0204000E0BEAAAB
|
Antipressan | Atenolol | Cardiovascular System | No data available |
|
Antiseptic Sore Mouth 1.29mg pastilles
1203030Z0BBAAAA
|
Boots (Dichlorobenzyl alcohol) | Dichlorobenzyl alcohol | Ear, Nose and Oropharynx | No data available |
|
Antiseptic Throat Drops Blackcurrant sugar free
1203030A0BCAAAD
|
Boots (Amylmetacresol) | Amylmetacresol | Ear, Nose and Oropharynx | No data available |
|
Antiseptic Throat Drops Cherry Menthol
1203030A0BCABAE
|
Boots (Amylmetacresol) | Amylmetacresol | Ear, Nose and Oropharynx | No data available |
|
Antiseptic Throat Drops Orange and Menthol with Vitamin C
1203030A0BCACAE
|
Boots (Amylmetacresol) | Amylmetacresol | Ear, Nose and Oropharynx | No data available |
|
Antithrombin alfa 1,750unit inf vials
0211000AAAAAAAA
|
Antithrombin alfa | Antithrombin alfa | Cardiovascular System | No data available |
|
Antithymocyte immunoglobulin (rabbit) 25mg inf vials
0802020X0AAAAAA
|
Antithymocyte immunoglobulin | Antithymocyte immunoglobulin | Malignant Disease and Immunosuppression | No data available |
|
Anturan 100mg tablets
1001040P0BBAAAA
|
Anturan | Sulfinpyrazone | Musculoskeletal and Joint Diseases | No data available |
|
Anturan 200mg tablets
1001040P0BBABAC
|
Anturan | Sulfinpyrazone | Musculoskeletal and Joint Diseases | No data available |
|
Anugesic HC cream
0107020J0BBAAAA
|
Anugesic HC | Hydrocortisone | Gastro-Intestinal System | No data available |
|
Anzemet 200mg tablets
0406000Z0BBABAB
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet 50mg tablets
0406000Z0BBAAAA
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet IV 100mg/5ml solution for injection ampoules
0406000Z0BBADAD
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet IV 12.5mg/0.625ml solution for injection ampoules
0406000Z0BBACAC
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzupgo 20mg/g cream
1305030M0BBAAAA
|
Anzupgo | Delgocitinib | Skin | No data available |
|
Apclaven XL 150mg capsules
0403040W0CGACAE
|
Apclaven XL | Venlafaxine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.